The Mundipharma global network of independent associated companies seeks to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned the network has a presence in over 120 countries. As a network, we have a strong track record of building successful alliances to license, develop and market medicines that improve patients’ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think we see what others don’t by challenging conventional wisdom and asking different and challenging questions. We are global leaders in pain medicines, with a significant, and growing presence in our three other core therapeutic areas of respiratory, oncology and biosimilars. However, we are also open to new partnership opportunities that will enable us to realize the potential of medicines at all stages of maturity across other therapy areas. For more information see www.mundipharma.com Mundipharma International Limited is part of and provides support to the Mundipharma network.
View Top Employees from Modimundi PharmaWebsite | http://www.mundipharma.com |
Revenue | $2 billion |
Employees | 2,288 (2,288 on RocketReach) |
Founded | 1952 |
Phone | +44 1223 424211 |
Industry | Pharmaceuticals, Biotechnology, Drug Manufacturing & Research, Business development, Market access, Healthcare, Alliance management, Launch leadership, Brand building, External affairs, Respiratory, Inflammation, Pain, Oncology, Life cycle management |
Keywords | Global Pharmaceuticals, Oncology |
Competitors | Amneal Pharmaceuticals, Chiesi Group, Eisai Inactive Page, Ethypharm, Helsinn Group |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 54171 Companies, NAICS Code 325413 Companies, NAICS Code 5417 Companies, NAICS Code 541 Companies, NAICS Code 325 Companies, NAICS Code 541711 Companies, NAICS Code 54 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies |
Looking for a particular Modimundi Pharma employee's phone or email?
The Modimundi Pharma annual revenue was $2 billion in 2024.
Rick Lones is the Vice President, Global Head of Medical Affairs of Modimundi Pharma.
2,288 people are employed at Modimundi Pharma.
The NAICS codes for Modimundi Pharma are [3254, 54171, 325413, 5417, 541, 325, 541711, 54, 32541, 32].
The SIC codes for Modimundi Pharma are [283, 28].